| A-01 Registration at the conference venue Tuesday 14:00-18:00 |
| A-02 Opening ceremony and welcome reception Tuesday 19:30-21:00 |
| B-01 Registration at the conference venue Wednesday 08:00-08:45 |
| B-02 Welcome and Introduction Wednesday 08:45-09:00 |
| B-03 Nigel Klein A biological perspective on immune response to drug treatment (intended and unintended effects) Wednesday 09:00-09:40 |
| B-04 Hans Peter Grimm Intricate PK and PD for the novel immunocytokine CEA-IL2v and their pre-clinical to clinical translation Wednesday 09:40-10:00 |
| B-05 Kirill Peskov Investigation of anti-CTLA-4 immuno-oncology therapy through a quantitative systems pharmacology model Wednesday 10:00-10:20 |
| B-06 Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter Wednesday 10:20-11:40 |
| B-07 Kapil Gadkar A Six-Stage Workflow for Robust Application of Systems Pharmacology Wednesday 11:40-12:00 |
| B-08 Rob van Wijk The zebrafish as model for translational systems pharmacology: expanding the allometric scale in vertebrates with five orders of magnitude Wednesday 12:00-12:20 |
| B-09 Lunch Wednesday 12:20-13:50 |
| B-10 Shasha Jumbe Introduction to the Gates' Healthy Birth, Growth & Development knowledge integration project Wednesday 13:50-14:05 |
| B-11 Louise Ryan Trajectory modelling based on early childhood longitudinal growth data Wednesday 14:05-14:45 |
| B-12 Niclas Jonsson Determinants for physical growth patterns in low- and middle-income countries Wednesday 14:45-15:05 |
| B-13 Nick Holford Announcement of WCoP 2016 Wednesday 15:05-15:10 |
| B-14 Tea break, poster and software session II: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter Wednesday 15:10-16:40 |
| B-15 Mélanie Wilbaux Characterizing and Forecasting Individual Weight Changes in Term Neonates Wednesday 16:40-17:00 |
| B-16 Nick Holford Growth and decline of body size and composition – Prediction of the transition from pre-diabetes to Type 2 diabetes in humans Wednesday 17:00-17:20 |
| B-18 Tram Nguyen The paradox of highly effective sofosbuvir combo therapy despite slow viral decline Wednesday 17:40-18:00 |
| B-19 Rik Schoemaker Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children Wednesday 18:00-18:20 |
| B-20 Special surprise... Wednesday 18:30-18:50 |
| C-01 Elin Svensson Bedaquiline's exposure-response relationship revealed through modeling of mycobacterial load Thursday 08:45-09:10 |
| C-02 Solène Desmée Joint modelling for nonlinear longitudinal PSA kinetics and survival data in metastatic prostate cancer patients Thursday 09:10-09:35 |
| C-03 Stein Schalkwijk A physiologically-based population pharmacokinetic analysis to assess a lower efavirenz dose of 400 mg once daily in HIV-infected pregnant women. Thursday 09:35-10:00 |
| C-04 Presentation of Lewis Sheiner student session awards Thursday 10:00-10:05 |
| C-05 Coffee break, poster and software session III: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter Thursday 10:05-11:30 |
| C-06 Matts Kågedal Time-to-Event Modeling of Peripheral Neuropathy – Platform Mega-Analysis of Eight vc-MMAE Antibody-Drug Conjugates (ADCs) Thursday 11:30-11:50 |
| C-07 Lucy Hutchinson Mixed-effect modelling of transient tumour growth dynamics following anti-angiogenic therapy Thursday 11:50-12:10 |
| C-08 Maria Luisa Sardu Modelling of classified individual tumor lesions in metastatic colorectal cancer (mCRC) patients using delay differential equations. Thursday 12:10-12:30 |
| C-09 Lunch Thursday 12:30-13:50 |
| C-10 Robert Bauer An overview of Estimation-Maximization Algorithms Used in Population Analysis Methods Thursday 13:50-14:35 |
| C-11 Brian Corrigan Announcement of ACoP7 Thursday 14:35-14:40 |
| C-12 Tea break, poster and software session IV: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter Thursday 14:40-16:00 |
| C-13 Yevgen Ryeznik Adaptive dose finding for time-to-event outcomes with adaptive choice of patient number based on response rate Thursday 16:00-16:20 |
| C-14 Sebastian Wicha A general pharmacodynamic interaction model based on the Bliss Independence criterion Thursday 16:20-16:40 |
| C-15 Martin Fink Improving priors for human mAb linear PK parameters by using half-lives from pre-clinical studies Thursday 16:40-17:00 |
| C-16 David McDougall The Impact of Model Selection for Personalised Dosing Thursday 17:00-17:20 |
| C-17 Social event: Buses depart from the Conference Venue at 19:30 Thursday 20:00-01:00 |
| D-01 Lutz Harnisch Modelling and simulation of neurological endpoints (modified Rankin Scale [mRS] and National Institute of Health Stroke Scale [NIHSS]) to aid clinical trial design in intracerebral hemorrhage (ICH) Friday 09:00-09:20 |
| D-02 Oliver Sander Model-based development of the secukinumab dosing regimen for the treatment of moderate-to-severe chronic plaque psoriasis Friday 09:20-09:40 |
| D-03 Rasmus Juul Kildemoes Repeated time to event modelling of opioid consumption in postoperative pain Friday 09:40-10:00 |
| D-04 Thu Thuy Nguyen Limited sampling strategy for a population pharmacokinetic modelling of cocktail of phenotyping drugs Friday 10:00-10:20 |
| D-05 Preview of PAGE2017 Friday 10:20-10:30 |
| D-06 Coffee break Friday 10:30-11:00 |
| D-07 Sylvie Retout How disease modeling and model-based meta-analyses contributed to understanding the path forward after dose discontinuation of a Phase III study in Alzheimer's disease Friday 11:00-11:20 |
| D-08 Marc Vandemeulebroecke A longitudinal Item Response Theory model to characterize cognition over time in elderly subjects Friday 11:20-11:40 |
| D-09 Simon Buatois Utilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients Friday 11:40-12:00 |
| D-10 Closing remarks Friday 12:00-12:10 |
| D-11 Audience input for potential PAGE2017 topics Friday 12:10-12:30 |
